IDEX has entered into a definitive merger agreement to acquire Microfluidics International, a manufacturer of laboratory and commercial equipment used in the production of micro and nano scale materials for the pharmaceutical and chemical markets.
Subscribe to our email newsletter
Microfluidics’ product and service offerings are expected to enhance IDEX’s micro fluidics and micro particle technology position.
Microfluidics will operate as a stand-alone business within the IDEX Fluid and Metering segment.
IDEX chairman and CEO Larry Kingsley said Microfluidics’ leading technology in particle size reduction and nano-particle creation adds enabling technology to one of their key platforms supporting pharmaceutical research and production.
"Combining Microfluidics with our Quadro and Fitzpatrick pharma platform will allow for significant growth opportunities across the globe. We welcome the Microfluidics team to IDEX," Kingsley said.
Microfluidics CEO Michael Ferrara said the company has completed a significant transformation – evolving into an innovative, efficient and financially stable technology provider with a robust product line that continues to serve as the gold standard for nano-materials processing, particularly for pharmaceutical applications.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.